Optimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes

Journal of Diabetes Science and Technology

Volumn 1, Issue 1, 2007, Pages 62-71

  Rodbard, David ^a  

^a AMERICAN INSTITUTES FOR RESEARCH   (United States)

Author keywords

Clinical decision support; Diabetes; Glucose; Medical informatics; Self monitoring; Statistics; Variability

Indexed keywords

EID: 70349343578     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100111     Document Type: Article

References (37)

1. Karter AJ, Parker MM, Moffet HH, Spence MM, Chan J, Ettner SL, Selby JV. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29(8):1757-63.
2. Blonde L, Karter AJ. Current evidence regarding the value of self-monitored blood glucose testing. Am J Med. 2005 Sep; 118(Suppl 9A):20S-26S.
3. Karter, AJ, Ackerson, LM, Darbinian, JA, D'Agostino, RB, Ferrara, A, Liu, J, Selby J V. Self Monitoring of Blood Glucose Levels and Glycemic Control: The Northern California Kaiser Permanente Diabetes Registry. Am. J. Med 2001;111:1-9.
4. Pernick, NL, Rodbard D. Personal computer programs to assist with self-monitoring of blood glucose and self-adjustment of insulin dosage. Diabetes Care. 1986;9(1):61-9.
5. Mazze, RS, Lucido, D, Langer, O, Hartmann, K, Rodbard, D. Ambulatory glucose profle: representation of verifed self-monitored blood glucose data. Diabetes Care. 1987 Jan-Feb; 10(1):111-7.
6. Rodbard, D. Potential role of computers in clinical investigation and management of diabetes mellitus. Diabetes Care. 1988 Nov-Dec; 11 Suppl 1:54-61.
7. Berger, M, Rodbard, D. Computer simulation of plasma insulin and glucose dynamics after subcutaneous insulin injection. Diabetes Care. 1989 Nov-Dec; 12(10):725-36.
8. Berger MP, Rodbard D. Comput Methods Programs Biomed. 1991;34(4):241-53. A pharmacodynamic approach to optimizing insulin therapy.
9. Shultz, EK, Bauman A, Hayward, M, Rodbard, D, Holzman, R. Improved diabetic prognosis following telecommunication and graphical processing of diabetic data. Proc Annu Symp Comput Appl Med Care. 1991:53-7.
10. Berger, MP, Gelfand RA, Miller PL. Combining statistical, rule-based, and physiologic model-based methods to assist in the management of diabetes mellitus. Comput Biomed Res. 1990 Aug; 23(4):346-57.
11. Rodbard, D., Berger, M., and Pernick, N. Computer, networking, and information systems to facilitate delivery of health care to patients with diabetes. In: Baba, S., and Kaneko, T. (Eds.), Diabetes 1994, Proceedings of the 15th International Diabetes Federation Congress, Kobe, 6-11 November 1994. Elsevier, Amsterdam, pp. 800-803, 1995.
12. Rodbard, D., Vigersky, R. (2004) Development of Algorithms for Clinical Decision Support for Primary Care Providers, Annual Meeting, Philadelphia, PA, October 28, 2004. Diabetes Technology and Therapeutics, March, 2005;7(2):409.
13. Hirsch IB. Glycemic variability: it's not just about A1c anymore! Diabetes Technol Ther. 2005 Oct; 7(5):780-3.
14. Hirsch, IB, Brownlee, M. J Should minimal blood glucose variability become the gold standard of glycemic control? Diabetes Complications 2005 19(3):178-181.
15. Brownlee, M, Hirsch, IB. Glycemic variability: a hemoglobin A1cindependent risk factor for diabetic complications. JAMA. 2006 Apr. 12;295(14):1707-8.
16. Monnier, L, Mas E, Ginet C, Michel, F, Villon, L, Cristol, JP, Colette, C. Activation of oxidative stress by acute glucose fuctuations compared with sustained chronic hyperglycemia in patients with Type 2 diabetes. JAMA. 2006 Apr. 12;295(14):1681-7.
17. Ceriello, A, Hanefeld, M, Leiter, L, Monnier, L, Moses, A, Owens, D, Tajima, N, Tuomilehto, J, for the International Prandial Glucose Regulation (PGR) Study Group. Postprandial glucose regulation and diabetic complications. Arch Intern Med 2004;164:2090-2095.
18. Esposito K., Giugliano D, Nappo, F., Marfella R. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in Type 2 diabetes mellitus. Circulation 2004;110:214-219.
19. Yemelkova-Jurtschiev, TS, Kohler, C, Henkel, E, Leonhardt W, Fuecker, K, Hanefeld, M: Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000;23:1830-1834.
20. Meigs, JB, Nathan, DM, D'Agostino, RB, Wilson, PW. Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. Diabetes Care 2002;25:1845-1850.
21. Kilpatrick ES, Rigby AS, Atkin SL. The effect of glucose variability on the risk of microvascular complications in Type 1 diabetes. Diabetes Care. 2006;29(7):1486-90.
22. Hsu, W., Laffel, L., Meneghina L., McGill JB. An Electronic Logbook Maintains Improvement in Glycemic Control: Observational Assessment Following a Randomized Controlled Trial. Diabetes-55(Suppl. 2);2006:. A93. Poster 396-P.
23. Kovatchev, BP, Cox DJ, Gonder-Frederick, L, Clarke, WL. Methods for quantifying and monitoring home glucose profles exemplifed by an examination of blood glucose patterns in patients with Type 1 and Type 2 diabetes. Diabetes Technol Ther 2002;4:295-303.
24. Kovatchev, BP, Clarke, WL, Breton, M, Brayman K, McCall, A. Quantifying Temporal Glucose Variability in Diabetes via Continuous Glucose Monitoring: Mathematical Models and Clinical Application. Diabetes Technol Ther 2005;7(6):849-862.
25. Kovatchev, B P, Cox, DJ. Numerical estimation of HbA (1c) from routine self-monitoring data in people with Type 1 and Type 2 diabetes mellitus. Methods Enzymol. 2004;384:94-106.
26. Otto, E., Sharma, M., Bhensdadia, R., Kovatchev, B, Muralidharan. Relationship of Measures of Glucose Variability with Out of Control Glucose Results. Diabetes 55(Suppl. 2);2006:. A95. Abstract 405-P.
27. Schlichtkrull, J., Munck, O., Jersild M. (1965). The M-value, an index of blood-sugar control in diabetics. Acta Med Scand., 177, 95-102.
28. Service, F. J., O'Brien P. C., Rizza, R. A. (1987). Measurements of glucose control. Diabetes Care, 10, 225-237.
29. Skyler J. S. Alberti, G. M. (1980). Clinical assessment of metabolic control in insulin dependent diabetes mellitus. Diabetes Care, 3, 369-370.
30. Wojcicki J. (1995). "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res., 27, 41-42.
31. Rodbard, D. (2005) Improved Methods for Calculating a "Figure of Merit" for Blood Glucose Monitoring Data." Diabetes Technology Meeting, San Francisco CA, November 2005.
32. Nathan DM, Turgeon H, Regan S. Translation of Glycosylated Hemoglobin Levels into Mean Blood Glucose (MBG) Levels, Revisited. Abstract 408.5-P, Diabetes 2006;55(Suppl. 2):A96.
33. Saudek CD, Derr RL, Kalyani, RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA 2006;295:1688-1697.
34. Kennedy, L., Herman, W. H., Strange, P., Harris, A, for the GOAL A1c TEAM. Impact of Active Versus Usual Algorithmic Titration of Basal Insulin and Point-of-Care Versus Laboratory Measurement of HbA1c on Glycemic Control in Patients with Type 2 Diabetes. Diabetes Care 2006;29:1-8.
35. Raskin, P., Allen, P., Hollander P., Lewin A., Gabbay, R. A., Hu, P., Bode B., Garber, A., FOR THE INITIATE STUDY GROUP. Diabetes Care 2005;28:260-265.
36. Yki-Järvinen H., Kauppinen-Mäkelin, R., Tiikkainen M., Vähätalo, M., Virtano, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy K., McNulty, S., J. Hänninen, Levänen H., Lahdenperä, S., Lehtonen, R., Ryysy, L. Insulin Glargine or NPH combined with Metformin in Type 2 diabetes: the LANMET study. Diabetologia 2006;49:442-451.
37. Tukey, J. W. (1977). Exploratory data analysis. Reading, MA: Addison-Wesley Publishing Company.